SEC 13F Intelligence

Orbimed Advisors LLC / FBRX

Orbimed Advisors LLC’s Forte Biosciences Inc Position

Does Orbimed Advisors LLC own Forte Biosciences Inc (FBRX)? Yes — 1.20M shares worth $31M (+0.61% of its 13F portfolio) as of Q1 2026.

Position Value
$31M
Q1 2026
Shares
1.20M
% of Portfolio
+0.61%
Quarters Held
6
currently held

Position History FBRX

Reported value by quarter
Q4 ’24: $14MQ4 ’24Q1 ’25: $5MQ1 ’25Q2 ’25: $15MQ2 ’25Q3 ’25: $18MQ3 ’25Q4 ’25: $33MQ4 ’25Q1 ’26: $31MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.20M$31M+0.61%
Q4 20251.20M$33M+0.67%
Q3 20251.20M$18M+0.42%
Q2 20251.20M$15M+0.39%
Q1 2025593.1K$5M+0.11%
Q4 2024600.0K$14M+0.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of FBRX.